Self-care for the inflammatory bowel disease patient: What can the professional recommend?

Seminars in Gastrointestinal Disease

Volumn 12, Issue 4, 2001, Pages 223-236

  Oviedo, J ^a   Farraye, F A ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; FISH OIL; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; EXERCISE; FEMALE; HUMAN; LACTOSE INTOLERANCE; LIFESTYLE; NUTRITION; SELF CARE; SMOKING; STRESS; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COMPLEMENTARY THERAPIES; DIETARY FIBER; FATTY ACIDS, VOLATILE; FEMALE; FISH OILS; HUMANS; INFLAMMATORY BOWEL DISEASES; NUTRITION DISORDERS; PROBIOTICS; RISK FACTORS; SELF CARE; SMOKING; STRESS, PSYCHOLOGICAL;

EID: 0034764930     PISSN: 10495118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (121)

1. Effect of cigarrette smoking on recurrence of Crohn's disease
2. Non-smoking: A feature of ulcerative colitis
3. Inflammatory bowel disease and smoking - A Review
4. A meta-analysis of the role of smoking in inflammatory bowel disease
5. Mormons, smoking and ulcerative colitis
6. Prevalence of inflammatory bowel disease amongst mormoms in Britain and Ireland
7. Time relationship between cessation of smoking and onset of ulcerative colitis
8. Risk of ulcerative colitis among former and current cigarette smokers
9. Smoking and inflammatory bowel disease. A case-control study
10. Cigarette smoking and quality of life in patients with inflammatory bowel disease
11. Should patients with inflammatory bowel disease smoke?
12. Smoking habits in patients with inflammatory bowel disease
13. Effects of cigarrette smoking on the clinical course of ulcerative colitis
14. Effects of smoking on the presentation and clinical course of inflammatory bowel disease
15. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis
16. Impact of cessation of smoking on the course of ulcerative colitis
17. Smoking and ulcerative colitis
18. Ulcerative colitis responsive to smoking and to nicotine chewing gum in a patient with alpha I anti-trypsin deficiency
19. Steroid-sparin effect of transdermal nicotine in ulcerative colitis
20. Pilot trial of nicotine patches as an alternative to corticosteroids in ulcerative colitis
21. Transdermal nicotine in active ulcerative colitis
22. Testing nicotine gum for ulcerative colitis. Experience with single-patient trials
23. Transdermal nicotine for active ulcerative colitis
24. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial
25. Transdermal nicotine as maintenance therapy for ulcerative colitis
26. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis
27. Outcome of ulcerative colitis after treatment with transdermal nicotine
28. Nicotine enemas for active ulcerative colitis - A pilot study
29. Pharmacokinetics of nicotine carbomer enemas: A new treatment for ulcerative colitis
30. Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: A pilot study
31. A dose ranging pharmacokinetic study of nicotine tartrate following single-dose delayed-release oral and intravenous administration
32. Nicotine therapy for ulcerative colitis: A review of rationale, mechanisms, pharmacology, and clinical results
33. Smoking and inflammatory bowel disease
34. Cigarette smoking and risk of clinical relapse in patients with Crohn's disease
35. Effect of cigarette smoking on the course of Crohn's disease
36. Oral contraceptive use and the clinical course of Crohn's disease: A prospective cohort study
37. Smoking in Crohn's disease: Effect on localization and clinical course
38. Effects of cigarette smoking on the long-term course of Crohn's disease
39. Inflammatory bowel disease: Is there any relation between smoking status and disease presentation?
40. Helping patients with Crohn's disease quit smoking
41. Attitudes toward smoking and smoking behaviors of patients with Crohn's disease
42. The relationship between heritability and smoking habits in Crohn's disease
43. Effects of current and former cigarette smoking on the clinical course of Crohn's disease
44. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease
45. Patients' awareness of adverse relation between Crohn's disease and their smoking: Questionnaire survey
46. Decreased severity of Crohn's disease after smoking cessation, preliminary results of a prospective intervention study
47. Smoking cessation and the course of Crohn's disease: An intervention study
48. The role of nicotine in smoking-related cardiovascular disease
49. Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy
50. The relevance of tobacco-specific nitrosamines to human cancer
51. Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease
52. Therapeutic value of graded aerobic exercise training in rheumatoid arthritis
53. Changes in the gastrointestinal mucosa after long-distance running
54. Gastrointestinal symptoms in long-disance runners, cyclists and triathletes: Prevalence, medication, and etiology
55. Gastrointestinal symptoms during long-distance walking
56. Reversible ischemic colitis in a high endurance athlete
57. The epidemiology of physical activity and cancer
58. Potential benefits and hazards of physical activity and exercise on the gastrointestinal tract
59. Occupational distribution of inflammatory bowel disease among German employees
60. A. Risk indicators for inflammatory bowel disease
61. Preillness non dietary factors and habits in inflammatory bowel disease
62. The effects of physical exercise on patients with Crohn's disease
63. Osteoporosis and determinants of bone density in patients with Crohn's disease
64. Effect of a low-impact exercise program on bone mineral density in Crohn's disease: A randomized controlled trial
65. Psychological distress and levels of disease activity in inflammatory bowel disease
66. A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease
67. Do life events or depression exacerbate inflammatory bowel disease? A prospective study
68. Psychological distress, social support, and disease activity in patients with inflammatory bowel disease
69. Health status and healthcare use in persons with inflammatory bowel disease. A national sample
70. Stress and exacerbation in ulcerative colitis: A prospective study of patients enrolled in remission
71. Management of Crohn's disease in adults
72. Managing patients' concerns
73. Enteral nutrition in inflammatory bowel disease
74. Nutrition and inflammatory bowel disease
75. Zinc deficiency: A complication of Crohn's disease
76. Serum zinc and taste acuity in Tel-Aviv patients with inflammatory bowel disease
77. Folate deficiency in chronic inflammatory bowel diseases
78. National cooperative Crohn's disease study: Adverse reactions to drugs
79. The relationship between habits of food consumption and reported reactions to food in people with inflammatory bowel disease testing the limits
80. Diet and inflammatory bowel disease: A case-control study
81. Prevention of bone mineral loss in patients with Crohn's disease by long term oral vitamin D supplemetation
82. Micronutrients and the risk of colorectal adenomas
83. Zinc deficiency as a problem in patients with Crohn's disease and fistula formation
84. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis: A case-controlled study
85. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis
86. Hyperhomocystineimia and inflammatory bowel disease: Prevalence and predictors in a cross-sectional study
87. Dietary recommendations for active and inactive ulcerative colitis
88. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease
89. Diversion colitis: A nutritional deficiency syndrome
90. Inflammatory bowel disease: Etiology, and pathogenesis
91. Treatment of diversion colitis with short-chain fatty acid irrigation
92. Topical treatment of refractory distal colitis with 5-ASA and sodium butyrate
93. Dietary supplementation with fish oil in ulcerative colitis
94. Treatment of ulcerative colitis with fish oil supplementation: A prospective 12-month randomized controlled study
95. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease
96. Randomized clinical trial of plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis
97. Crohn's disease: Maintenance of remission by diet
98. Treatment of active Crohn's disease by exclusion diet
99. Food intolerance and Crohn's disease
100. Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics
101. Double blind comparison of an oral Eschericia Coli preparation and mesalazine in maintaining remission of ulcerative colitis
102. Non-pathogenic Eschericia Coli versus mesalazine for the treatment of ulcerative colitis: A randomized trial
103. Probiotics in infective diarrhoea and inflammatory bowel diseases
104. Probiotics: Science or snake oil
105. Nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease
106. Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease
107. Toxicity of non-steroidal anti-inflammatory drugs in the large intestine
108. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease
109. Gastrointestinal toxicity of nonsteroidal antiinflamatory drugs
110. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: A case-control study
111. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
112. Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease
113. Exacerbation of inflammatory bowel disease associated with use of celecoxib
114. Nonsteroidal anti-inflammatory drugs, enterocolonic ulceration and inflammatory bowel disease
115. Alternative patient care methods
116. Complementary medicine use by patients with inflammatory bowel disease
117. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease
118. Chinese herbal medicine
119. Advising patients who seek alternative medical therapies